News Snapshot:
Washington DC [US], August 29 (ANI): The COVID-19 vaccine made by China 's Sinopharm was less effective than others at preventing infection, hospitalization and death, according to a new study. A report published by The Wall Street Journal stated that this study, conducted by the kingdom of Bahrain and Columbia University researchers, especially holds true among people over 50. This comes as Chinese vaccines have become a major factor in Beijing's diplomacy manoeuvres, especially in developing countries with fewer resources. The WSJ report stated that despite high levels of inoculation with the Sinopharm vaccine, Bahrain in May started giving booster...
